Business

CNBC’s Jim Cramer said Tuesday it appears that cannabis companies could be seeing some “meaningful differentiation.” He took a look at the chart patterns of stocks in the sector as interpreted by Tim Collins, a technician and Cramer colleague at RealMoney.com. “The charts, as interpreted by Tim Collins, suggest that GW Pharma and Village Farms
0 Comments
CNBC’s Jim Cramer revealed Monday that he has a “hard pass” on newly-public Luckin Coffee. That’s because initial public offerings of Chinese-owned companies have brought too much pain, he said. Luckin, the Beijing-based chain that wants to surpass Starbucks as the biggest coffee chain in that country, surged as much as 50% after opening at $25
0 Comments
Arena Pharmaceuticals Inc.: “We like Arena. We’ve liked it. I know it’s speculative. It’s O.K. for a spec, as long as you’re willing to understand that this is not Merck. “ IAC/InterActiveCorp.: “I thought that was an amazing quarter. I think that company is so inexpensive, I frankly don’t even understand it. I say it’s
0 Comments
Alex Gorsky, CEO of Johnson & Johnson Adam Jeffery | CNBC Johnson & Johnson‘s pharmaceutical business will take the spotlight Wednesday at its annual meeting with analysts as the company tries to allay investors’ concerns over its talc-based baby powder. The New Brunswick, New Jersey, based health-care conglomerate makes a wide range of products, including
0 Comments
The 2019 Cadillac CTS-V CNBC | Mack Hogan Cadillac, the luxury arm of auto giant General Motors, appeared to not anticipate the insatiable hunger consumers have for SUVs and crossovers.  While Cadillac tried to out-German BMW and Mercedes with a lineup of sports sedans with impressive driving dynamics and great prices, the Germans padded their
0 Comments